Skip to Main Content

An official website of the United States government

Here you can browse the complete list of projects for PLCO whose requests for data/biospecimens were approved.

Name Principal Investigator Institution Study Date Approved Project ID
Estimate heritability of survival for selected diseases Jianxin Shi National Cancer Institute PLCO Aug 20, 2020 PLCO-661
Risk Factors for Lung Cancer in Never Smokers: Insight from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Dataset Farouk Dako University of Pennsylvania PLCO Aug 18, 2020 PLCO-660
Associations between Dietary Plant Seed Consumption and Overall and Cause-Specific Mortality Risk Jiaqi Huang National Cancer Institute PLCO Aug 5, 2020 PLCO-653
Germline genetics of prostate cancer, PSA, and BPH using the expanded PLCO GWAS Sonja Berndt National Cancer Institute PLCO Aug 5, 2020 PLCO-659
Deep Learning for Chest X-Ray Radiological Findings Related to Covid-19 Bambang Trilaksono PT Riset Kecerdasan Buatan PLCO Jul 24, 2020 PLCOI-656
Dietary acid load and pancreatic cancer incidence and mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Guo-Chao Zhong Zhong The Second Affiliated Hospital of Chongqing Medical University PLCO Jul 24, 2020 PLCO-655
Low-carbohydrate diets and the risk of pancreatic cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Guo-Chao Zhong The Second Affiliated Hospital of Chongqing Medical University PLCO Jul 24, 2020 PLCO-654
Association of ultra-processed food consumption with cardiovascular mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Guo-Chao Zhong the Second Affiliated Hospital of Chongqing Medical University PLCO Jul 22, 2020 PLCO-652
Using Machine Learning for the Early Diagnosis of Pancreatic Cancer Carol Hersh Great Neck South High School PLCO Jul 21, 2020 PLCO-651
BRCA and HNPCC Carriers in PLCO Paul Pinsky NCI PLCO Jul 17, 2020 PLCO-644
Impact of Prostatitis and Benign Prostate Hyperplasia (BPH) on risk factors for Prostate Cancer Andrew Marks Claremont Graduate University PLCO Jul 17, 2020 PLCO-641
Prediction of an individual's smoking habits using saliva microbial signatures Manfred Kayser Erasmus MC Medical Center University Rotterdam PLCO Jul 17, 2020 PLCO-647
Blood groups and inflammatory marker levels Charles Rabkin DCEG PLCO Jul 17, 2020 PLCO-646
Chocolate consumption and mortality in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Guo-Chao Zhong The Second Affiliated Hospital of Chongqing Medical University PLCO Jul 17, 2020 PLCO-645
Zinc intake and primary liver cancer incidence and mortality in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Yun-Bing Wang The second affiliated hospital of Chongqing Medical University PLCO Jul 17, 2020 PLCO-650
Copper intake and primary liver cancer incidence and survival in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Yun-Bing Wang The second affiliated hospital of Chongqing Medical University PLCO Jul 17, 2020 PLCO-649
Adherence to the 2018 World Cancer Research Fund/American Institute for Cancer Research cancer prevention recommendations and pancreatic cancer incidence and mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Guo-Chao Zhong The Second Affiliated Hospital of Chongqing Medical University PLCO Jun 30, 2020 PLCO-642
Genderd differences in stage and radiotherapy Cristina Sarasqueta Instituto Biodonostia PLCO Jun 26, 2020 PLCO-640
Evaluating six-step parsimonious quadratic logistic regression for risk prediction Stuart Baker National Cancer Institute PLCO Jun 18, 2020 PLCO-637
Verifying Explanatory Methods Thomas Lukasiewicz University of Oxford PLCO Jun 18, 2020 PLCO-638